MTM(SH:688029) Xin Lang Zheng Quan·2025-09-29 09:15Core Viewpoint - Nanwei Medical Technology Co., Ltd. announced an adjustment to the maximum repurchase price due to the implementation of the 2025 semi-annual profit distribution, lowering it from 95.54 CNY/share to 95.04 CNY/share, effective from September 26, 2025 [1][4]. Group 1: Share Repurchase Overview - On April 21, 2025, the company approved a share repurchase plan with a total fund of no less than 30 million CNY and no more than 50 million CNY, with a maximum repurchase price of 96.54 CNY/share [2]. - Following the 2024 annual profit distribution, the maximum repurchase price was adjusted to 95.54 CNY/share [2]. Group 2: Semi-Annual Profit Distribution - The company plans to distribute a cash dividend of 5.00 CNY (including tax) for every 10 shares, with the record date set for September 25, 2025, and the ex-dividend date on September 26, 2025 [3]. Group 3: Price Adjustment Calculation - The adjustment of the maximum repurchase price is based on the cash dividend distribution, calculated as follows: adjusted maximum repurchase price = (previous maximum repurchase price - cash dividend) / (1 + change in circulating shares ratio) [4]. - The cash dividend per share is approximately 0.4973 CNY/share, calculated from the total shares participating in the distribution [4]. Group 4: Estimated Repurchase Quantity - With the adjusted maximum repurchase price of 95.04 CNY/share, the estimated number of shares to be repurchased at the upper limit of 50 million CNY is approximately 526,094 shares, representing about 0.28% of the total share capital [5]. - At the lower limit of 30 million CNY, the estimated number of shares to be repurchased is approximately 315,657 shares, representing about 0.17% of the total share capital [5].